Doctor profile · Federal record
Dr. Natallia Fiadorchanka, M.D.
Dermatology Physician (CMS: Dermatology) · Brooklyn, NY
- NPI 1215295480
- Accepts Medicare
- MIPS 81.0 / 100 · 2023
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1938 Coney Island Ave
Brooklyn, NY 112306513
(718) 905-5000
fax (877) 991-8177
Credentials & registration
- NPI registered
- April 2012 — 14 yrs on file
- Profile last updated
- October 31, 2024
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #281234
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1215295480. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
16,056
Distinct HCPCS
10
Medicare allowed
$433,265
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 9,200 | 35 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,580 | 343 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 926 | 548 | $105 | |
17000 |
Destruction of precancer skin growth, 1 growth | 645 | 366 | $68 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 350 | 264 | $66 | |
11102 |
Biopsy of related skin growth, first growth | 247 | 215 | $115 | |
17110 |
Destruction of skin growth, 1-14 growths | 241 | 172 | $135 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 229 | 229 | $133 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 134 | 72 | $205 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 78 | 49 | $1 |
In context: peer comparison
Among 18 peers in this city , average services per provider: 254. This provider delivers 63× the peer median.Open Payments
Industry payments received
All-time total
$995
Transactions
41
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 9 | $321.44 | |
| Janssen Biotech, Inc. | 10 | $197.38 | |
| Arcutis Biotherapeutics, Inc. | 5 | $96.21 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $62.34 | |
| ABBVIE INC. | 2 | $49.59 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $48.95 | |
| Amgen Inc. | 2 | $47.69 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $43.74 | |
| LEO Pharma Inc. | 2 | $40.78 | |
| Dermavant Sciences, Inc. | 1 | $22.84 | |
| Verrica Pharmaceuticals Inc. | 1 | $22.78 | |
| UCB, Inc. | 1 | $21.43 | |
| Biofrontera Inc. | 1 | $19.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,832
Patients
2,012
Total drug cost
$204,976
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 1,396 | 418 | $39,073 |
| Ammonium Lactate | Generic | 681 | 231 | $20,811 |
| Clindamycin Phosphate | Generic | 401 | 189 | $26,525 |
| Mupirocin | Generic | 401 | 251 | $5,084 |
| Nystatin | Generic | 307 | 110 | $8,001 |
| Clotrimazole | Generic | 274 | 92 | $11,866 |
| Triamcinolone Acetonide | Generic | 263 | 155 | $4,902 |
| Clobetasol Propionate | Generic | 258 | 112 | $41,457 |
| Mometasone Furoate | Generic | 246 | 137 | $7,106 |
| Hydrocortisone | Generic | 185 | 112 | $1,649 |
Frequently asked questions
What is Dr. Natallia Fiadorchanka's medical specialty?
Dr. Natallia Fiadorchanka practices Dermatology Physician in Brooklyn, NY.
Where does Dr. Natallia Fiadorchanka practice?
Dr. Natallia Fiadorchanka practices at 1938 Coney Island Ave, Brooklyn, NY 112306513. Office phone: 7189055000.
What is Dr. Natallia Fiadorchanka's NPI?
Dr. Natallia Fiadorchanka's National Provider Identifier (NPI) is 1215295480, issued by NPPES.
Does Dr. Natallia Fiadorchanka accept Medicare assignment?
Yes. Dr. Natallia Fiadorchanka accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Natallia Fiadorchanka commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.